Mavri et al. Intensive Care Medicine Experimental 2015, 3(Suppl 1):A210 http://www.icm-experimental.com/content/3/S1/A210
POSTER PRESENTATION Open Access
Dexmetomidine, fentanyl and esmolol on prevention of the hemodynamic effects of laryngoscopy and endotracheal intubation. a prospective, randomized, double-blind study
M Mavri1, K Rellos1, I Pantazopoulos2, C Kampolis3, I Floros4, N Iacovidou5, T Xanthos6, C Pantazopoulos4*
From ESICM LIVES 2015Berlin, Germany. 3-7 October 2015
Intr
The hemodynamic effects of laryngoscopy and endotracheal intubation are well known. A variety of drugs, like fentanyl, esmolol and lately dexmetomidine, have been used in order to attenuate the stress response to laryngoscopy and endotracheal intubation. Esmolol is an ultrashort acting beta 1 selective adrenergic antagonist, while dexmetomidine is an alpha 2 adrenergic receptor agonist. Fentanyl is a short-acting opioid.
Objectives
The scientific objective of this study, was to compare the efficacy of dexmetomidine, fentanyl and esmolol for attenuation of sympathetic response during laryngoscopy and endotracheal intubation.
Methods
The present study included sixty (60) elective surgery patients with ASA 1 and 2, aged 20-60 years, who needed endotracheal intubation. Patients were randomly allocated into 3 groups. Each group included twenty patients (n = 20). Patients in group D (Dexmetomidine) received 1mcg/kg dexmetomidine with infusion in 10 min, patients in group F (Fentanyl) received 2 mcg/kg fentanyl, while in group E (Esmolol), patients received 2 mg/kg esmolol two min before induction. All patients had Mallampati and Cormack-Lehane Grades 1 or 2. All patients were intubated in less than 30 sec. Systolic, diastolic, mean arterial pressures and heart rates were measured before induction, before intubation and 1, 2, 4 and 10 min after intubation.
Results
When recorded values before induction and intubation were compared to the measurements of the groups, it was found that 4 and 10 min after intubation, heart rate in group D and systolic, diastolic and mean arterial pressures in group E, were lower than the other measurements. (p < 0.05).
Conclusions
Dexmedetomidine was superior than the other drugs in preventing laryngoscopy and intubation-related tachycardia. On the other hand, esmolol was superior in preventing systolic, diastolic and mean arterial pressure increases following laryngoscopy and intubation.
Authors details
1Central Clinic of Athens, Research and Treatment Medical Center, Anaesthesiology and Intensive Care, Athens, Greece. 2Evaggelismos General Hospital of Athens, Intensive Care Unit, Athens, Greece. 3Laiko General Hospital of Athens, University of Athens, Pathophysiology Clinic, Athens, Greece. 4Laiko General Hospital of Athens, University of Athens, Intensive Care Unit, Athens, Greece. 5University of Athens, Medical School, Neonatology, Athens, Greece. 6University of Athens, Medical School, MSc Cardiopulmonary Resuscitation, Athens, Greece.
Published: 1 October 2015
References1. Yavascaoglu B, Kaya FN, Baykara M, et al: A comparison of esmolol and dexmedetomidine for attenuation of intraocular pressure and haemodynamic responses to laryngoscopy and tracheal intubation. Eur J Anaesthesiol 2008, 25:517-19.
2. Atlee JL, Dhamee MS, Olund TL, et al: The use of esmolol, nicardipine, or their combination to blunt hemodynamic changes after laryngoscopy and tracheal intubation. Anesth Analg 2000, 90:280-5.
3. Adachi YU, Satomoto M, Higuchi H, et al: Fentanyl attenuates the hemodynamic response to endotracheal intubation more than the response to laryngoscopy. Anesth Analg 2002, 95:233-7.
4Laiko General Hospital of Athens, University of Athens, Intensive Care Unit, Athens, GreeceFull list of author information is available at the end of the article
2015 Pantazopoulos et al.; This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0
Web End =http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Mavri et al. Intensive Care Medicine Experimental 2015, 3(Suppl 1):A210 http://www.icm-experimental.com/content/3/S1/A210
Page 2 of 2
doi:10.1186/2197-425X-3-S1-A210Cite this article as: Mavri et al.: Dexmetomidine, fentanyl and esmolol on prevention of the hemodynamic effects of laryngoscopy and endotracheal intubation. a prospective, randomized, double-blind study. Intensive Care Medicine Experimental 2015 3(Suppl 1):A210.
Submit your manuscript to a journal and benet from:
7 Convenient online submission7 Rigorous peer review7 Immediate publication on acceptance7 Open access: articles freely available onlihttp://www.springeropen.com/
Web End =ne 7 High visibility within the eld7 Retaining the copyright to your article
Submit your next manuscript at 7 http://www.springeropen.com/
Web End =springeropen.com
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
The Author(s) 2015
Abstract
Issue Title: ESICM LIVES 2015
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer